To investigate the anti-tumour effects of EGFR siRNA-loaded PEGylated NPs, tumour bearing mice were treated with SSNs, PEG-SSNs, EGFR siRNA/SSNs, and EGFR siRNA/PEG-SSNs through the tail vein. Here, EGFR is linked to neoplasm.